246710 — T&R Biofab Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for T&R Biofab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-5,604	-11,083	-10,337	-13,419	-7,679
Depreciation
Amortisation
Non-Cash Items	461	2,322	1,865	3,069	-6,566
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4,485	-496	638	1,230	109
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-8,376	-7,562	-5,887	-6,963	-11,733
Capital Expenditures	-2,163	-8,883	-11,035	-12,730	-2,809
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,193	-24,893	28,613	-24,785	14,498
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	1,030	-33,777	17,578	-37,515	11,689
Financing Cash Flow Items	52.4	124	83.2	38.4	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	26,034	41,656	-219	29,585	-3,515
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	18,555	386	11,458	-14,894	-3,556